[1] |
Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies[J]. Surg Clin North Am, 2019, 99(2):337-355.
|
[2] |
Krell RW, Wei AC. Gallbladder cancer: surgical management[J]. Chin Clin Oncol, 2019, 8(4):36.
|
[3] |
Sternby Eilard M, Lundgren L, Cahlin C, et al. Surgical treatment for gallbladder cancer-a systematic literature review[J]. Scand J Gastroenterol, 2017, 52(5):505-514.
|
[4] |
Shukla SK, Singh G, Shahi KS, et al. Staging, treatment, and future approaches of gallbladder carcinoma[J]. J Gastrointest Cancer, 2018, 49(1):9-15.
|
[5] |
Salazar M, Ituarte C, Abriata MG, et al. Gallbladder cancer in South America: epidemiology and prevention[J]. Chin Clin Oncol, 2019, 8(4):32.
|
[6] |
Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location isa strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study[J]. Ann Surg, 2015, 261(4):733-739.
|
[7] |
Ethun CG, Postlewait LM, Le N, et al. A novel pathology-based preoperative risk score to predict locoregional residual and distant disease and survival for incidental gallbladder cancer: a 10-institution study from the U.S. extrahepatic biliary malignancy consortium[J]. Ann Surg Oncol, 2017, 24(5):1343-1350.
|
[8] |
Kim SH, Chong JU, Lim JH, et al. Optimal assessment of lymph node status in gallbladder cancer[J]. Eur J Surg Oncol, 2016, 42(2): 205-210.
|
[9] |
Sakata J, Shirai Y, Wakai T, et al. Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma[J]. Ann Surg Oncol, 2010, 17(7):1831-1840.
|
[10] |
Pilgrim CH, Groeschl RT, Turaga KK, et al. Key factors influencing prognosis in relation to gallbladder cancer[J]. Dig Dis Sci, 2013, 58(9):2455-2462.
|
[11] |
中华医学会外科学分会胆道外科学组,中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版)[J].中华外科杂志,2020,58(4):243-251.
|
[12] |
中华医学会外科学分会胆道外科学组. 胆囊癌诊断和治疗指南(2015版)[J]. 中华消化外科杂志,2015,14(11):881-890.
|
[13] |
Misra MC, Guleria S. Management of cancer gallbladder found asa surprise on a resected gallbladder specimen[J]. J Surg Oncol, 2006, 93(8):690-698.
|
[14] |
Yu LH, Yuan B, Fu XH, et al. Does anatomic resection get more benefits than wedge hepatectomy on the prognosis for pT3 unsuspected gallbladder cancer?[J]. J Laparoendosc Adv Surg Tech A, 2019, 29(11):1414-1418.
|
[15] |
Umemura A, Nitta H, Takahara T, et al. Identifying cystic vein perfusion area employing indocyanine green fluorescence imaging during laparoscopic extended cholecystectomy for clinical T2 gallbladder cancer[J]. Case Rep Gastroenterol, 2020, 14(1):110-115.
|
[16] |
Kosuge T, Sano K, Shimada K, et al. Should the bile duct be preserved or removed in radical surgery for gallbladder cancer?[J]. Hepatogastroenterology, 1999, 46(28):2133-2137.
|
[17] |
Araida T, Higuchi R, Hamano M, et al. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? results of a Japanese society of biliary surgery survey: a multicenter study[J]. Surg Today, 2009, 39(9):770-779.
|
[18] |
Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? a phase Ⅲmulticenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma[J]. Cancer, 2002, 95(8):1685-1695.
|
[19] |
Horgan AM, Amir E, Walter T, et al. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis[J]. J Clin Oncol, 2012, 30(16):1934-1940.
|
[20] |
Sharma A, Sharma KL, Gupta A, et al. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update[J]. World J Gastroenterol, 2017, 23(22):3978-3998.
|